thiazoles has been researched along with n-phenacylthiazolium bromide in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basgen, J; Bernhagen, J; Bucala, R; Cerami, A; Egan, J; Kapurniotu, A; Shih, D; Teichberg, S; Terlecky, I; Ulrich, P; Vasan, S; Wagle, D; Zhang, X | 1 |
| Ulrich, P; Zhang, X | 1 |
| Bland, H; Evershed, RP; Hofreiter, M; Martin, PS; Pääbo, S; Poinar, HN; Possnert, G; Spaulding, WG; Stankiewicz, BA | 1 |
| Stokstad, E | 1 |
| Minhas, HS; Thornalley, PJ | 1 |
| Cooper, ME; Darby, I; Forbes, J; Sastra, S; Scalbert, E; Soulis, T; Thallas, V | 1 |
| Boel, E; Christensen, M; Mortensen, SB; Oturai, PS; Pedersen, KE; Rolin, B | 1 |
| Cerami, A; Ulrich, P | 1 |
| Bakala, H; Depreux, P; Fourmaintraux, E; Schwedler, SB; Striker, GE; Striker, LJ; Verbeke, P; Vilar, J; Weiss, MF | 1 |
| Makita, Z; Takeuchi, M; Yamagishi, S | 1 |
| Bu, FQ; Chen, YH; Hu, XL; Liu, JY; Liu, ZQ; Liu, ZY; Zhou, QL | 1 |
| Ping, L; Tang, X; Zhao, G | 1 |
| Kistler, L | 1 |
| Yamagishi, S | 1 |
| Chang, PC; Chen, CC; Chen, YW; Jheng, YH; Lin, YF; Tsai, SC; Wang, CY | 1 |
| Chang, PC; Chong, LY; Kao, MJ; Tsai, SC | 1 |
| Bradke, BS; Vashishth, D | 1 |
| Chang, CY; Chang, PC; Chao, YC; Jheng, YH; Lee, N; Liu, DM; Yang, C; Yu, MC; Yu, SH; Yu, XH | 1 |
| Burbano, HA; Furtwängler, A; Gutaker, RM; Reiter, E; Schuenemann, VJ | 1 |
| Chang, PC; Feng, F; Lin, JH; Wang, CH; Yu, MC | 1 |
3 review(s) available for thiazoles and n-phenacylthiazolium bromide
| Article | Year |
|---|---|
Pharmaceutical intervention of advanced glycation endproducts.
Topics: Animals; Glycation End Products, Advanced; Humans; Maillard Reaction; Thiazoles | 2001 |
[OPB-9195].
Topics: Animals; Diabetic Angiopathies; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines | 2002 |
Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders.
Topics: Aging; Animals; Cross-Linking Reagents; Diabetes Complications; Glycation End Products, Advanced; Humans; Thiazoles | 2012 |
17 other study(ies) available for thiazoles and n-phenacylthiazolium bromide
| Article | Year |
|---|---|
An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
Topics: Amyloid beta-Peptides; Animals; Cross-Linking Reagents; Diabetes Mellitus; Glucose; Glycation End Products, Advanced; Immunoglobulin G; Rats; Serum Albumin; Thiazoles | 1996 |
Pharmacological reversal of advanced glycation end-product-mediated protein crosslinking.
Topics: Animals; Diabetes Mellitus; Erythrocytes; Glycation End Products, Advanced; Immunoglobulin G; Rats; Thiazoles | 1997 |
Molecular coproscopy: dung and diet of the extinct ground sloth Nothrotheriops shastensis.
Topics: Animals; Base Sequence; Cloning, Molecular; Diet; DNA, Mitochondrial; DNA, Plant; DNA, Ribosomal; Feces; Fossils; Maillard Reaction; Molecular Sequence Data; Plants; Polymerase Chain Reaction; Ribulose-Bisphosphate Carboxylase; RNA, Ribosomal; Sloths; Thiazoles | 1998 |
A fruitful scoop for ancient DNA.
Topics: Animals; Diet; DNA, Mitochondrial; DNA, Plant; Feces; Fossils; Hominidae; Humans; Sloths; Thiazoles | 1998 |
Rapid hydrolysis and slow alpha,beta-dicarbonyl cleavage of an agent proposed to cleave glucose-derived protein cross-links.
Topics: Cross-Linking Reagents; Glycation End Products, Advanced; Glycosylation; Hydrolysis; Molecular Structure; Thiazoles; Time Factors | 1999 |
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.
Topics: Animals; Blood Pressure; Blood Vessels; Diabetes Mellitus, Experimental; Glycated Hemoglobin; Glycation End Products, Advanced; Immunohistochemistry; Male; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Thiazoles | 2000 |
Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats.
Topics: Albuminuria; Animals; Collagen; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drinking; Eye; Female; Glycation End Products, Advanced; Kidney; Organ Size; Phenazines; Radiopharmaceuticals; Rats; Rats, Wistar; Serum Albumin; Serum Albumin, Radio-Iodinated; Solubility; Tail; Tendons; Thiazoles; Weight Gain | 2000 |
N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.
Topics: Animals; Arginine; Collagen; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Mesangium; Glycation End Products, Advanced; Kidney; Kidney Glomerulus; Lysine; Mice; Mice, Inbred C57BL; Proteinuria; Thiazoles | 2001 |
[Study on the interaction of PTB and serum albumin by fluorescence method].
Topics: Animals; Cattle; Energy Transfer; Fluorescence; Humans; Hypoglycemic Agents; Protein Binding; Serum Albumin; Serum Albumin, Bovine; Spectrometry, Fluorescence; Thermodynamics; Thiazoles | 2007 |
Wood identification with PCR targeting noncoding chloroplast DNA.
Topics: DNA, Chloroplast; Polymerase Chain Reaction; Thiazoles; Trees | 2011 |
Ancient DNA extraction from plants.
Topics: Cetrimonium; Cetrimonium Compounds; Chloroform; DNA, Plant; Fossils; Plants; Thiazoles | 2012 |
Osseous wound repair under inhibition of the axis of advanced glycation end-products and the advanced glycation end-products receptor.
Topics: Animals; Collagen Type I; Disease Models, Animal; Fibronectins; Glycation End Products, Advanced; Guanidines; Male; Mandibular Injuries; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Thiazoles; Tumor Necrosis Factor-alpha; Wound Healing; X-Ray Microtomography | 2015 |
N-Phenacylthiazolium bromide inhibits the advanced glycation end product (AGE)-AGE receptor axis to modulate experimental periodontitis in rats.
Topics: Alveolar Bone Loss; Animals; Blood Glucose; Cell Adhesion Molecules; Cell Culture Techniques; Cell Line; Cell Survival; Collagen Type I; Disease Models, Animal; Disease Progression; Fibronectins; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Immunohistochemistry; Male; Periodontal Ligament; Periodontitis; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Thiazoles; Tumor Necrosis Factor-alpha | 2014 |
N-phenacylthiazolium bromide reduces bone fragility induced by nonenzymatic glycation.
Topics: Adult; Aged, 80 and over; Animals; Biomechanical Phenomena; Bone Remodeling; Cadaver; Collagen Type I; Fractures, Bone; Glycation End Products, Advanced; Humans; Male; Middle Aged; Rats; Rats, Inbred Lew; Ribose; Thiazoles | 2014 |
pH-Responsive Hydrogel With an Anti-Glycation Agent for Modulating Experimental Periodontitis.
Topics: Alveolar Bone Loss; Animals; Hydrogel, Polyethylene Glycol Dimethacrylate; Periodontitis; Rats; Rats, Sprague-Dawley; Thiazoles | 2016 |
Extraction of ultrashort DNA molecules from herbarium specimens.
Topics: Cetrimonium; Cetrimonium Compounds; DNA, Ancient; DNA, Plant; Gene Library; Polymerase Chain Reaction; Sequence Analysis, DNA; Thiazoles | 2017 |
Modulation of periodontitis progression using pH-responsive nanosphere encapsulating metronidazole or N-phenacylthialzolium bromide.
Topics: Animals; Anti-Infective Agents; Chitosan; Disease Models, Animal; Disease Progression; Lactic Acid; Metronidazole; Nanospheres; Periodontitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Thiazoles | 2018 |